ANKYRBIO
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system. The company is based in Pittsburgh, Pennsylvania.
ANKYRBIO
Industry:
Biotechnology Health Care Therapeutics
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.ankyrbio.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
225 K USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Forge Therapeutics
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Investors List
National Science Foundation
National Science Foundation investment in Grant - Ankyrbio
Official Site Inspections
http://www.ankyrbio.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Ankyrbio"
AnkyrBio — AnkyrBio
AnkyrBio is a preclinical stage biotechnology company focused on commercializing its proprietary anchoring system, AnkyRx™, for binding biological drugs to cellular surfaces. Drug washout …See details»
Ankyrbio - Crunchbase Company Profile & Funding
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system. The company is based in Pittsburgh, Pennsylvania.See details»
Ankyrbio - Funding, Financials, Valuation & Investors - Crunchbase
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system.See details»
Investors — AnkyrBio
AnkryBio LLC. 2403 Sidney St., Ste 255, Pittsburgh, PA, 15203, USA [email protected]See details»
Ankyrbio LLC | www.inknowvation.com
Ankyrbio LLC . Profile last edited on: 10/19/20 CAGE: 86U75 UEI: NG5TMNJJRZN9. Business Identifier: Eye Therapeutics: solves drug washout problem allowing drugs to adhere locally in …See details»
Ankyrbio LLC Company Profile | Pittsburgh, PA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ankyrbio LLC of Pittsburgh, PA. Get the latest business insights from Dun & Bradstreet.See details»
Ankyrbio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system.See details»
AnkyrBio LLC - VentureRadar
Founded in 2018, AnkyrBio is developing a drug delivery platform to treat diseases at wet surfaces of the body. The central idea is to anchor biologics to wet surfaces so that they act for …See details»
ANKYRBIO LLC - CAGE.report
Ankyrbio Llc has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 86U75 was listed as their …See details»
Ankyrbio LLC Details - govtribe.com
Ankyrbio LLC UEI NG5TMNJJRZN9. Primary NAICS Category 541714 - Research and Development in Biotechnology (except Nanobiotechnology) SBA Certifications Self …See details»
AnkryBio - Products, Competitors, Financials, Employees, …
AnkyrBio operates as a preclinical biotechnology company specializing in drug delivery technology within the pharmaceutical industry. The company's main innovation, AnkyRx, …See details»
Ankyrbio - Crunchbase
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system.See details»
Technology - AnkyrBio
AnkyrBio’s anchor system, called AnkyRx™, is developed to bind biologic drugs to extracellular proteins on cells and surfaces such as the cornea. AnkyRx™ attaches and retains the drug on …See details»
Ankyrbio (NG5TMNJJRZN9)
Ankyrbio (UEI NG5TMNJJRZN9, CAGE 86U75) based in Pittsburgh PA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
AnkyrBio: Extending Drug Efficacy with Novel Ocular Therapeutics …
The AnkyrBio technology enables therapeutics to be administered in eye drops and remain active on the surface of the eye for up to 3-5 days. This unique technology localizes the therapeutics …See details»
Darren Wolfe, PhD - Founder & CEO - Fathom Pharma - LinkedIn
AnkyrBio Nov 2018 - Dec 2021 3 years 2 months. Pittsburgh, Pennsylvania, United States Board of Directors Member Neuro Kinetics, Inc. Jan 2017 - May 2021 4 ...See details»
Partnering — AnkyrBio
AnkyrBio is interested exploring in mutually beneficial collaborations. AnkyrRx™ anchor technology will offer our partners the opportunity to establish market leading products through: …See details»
Grant - Ankyrbio - 2019-11-22 - Crunchbase Funding Round Profile
Nov 22, 2019 Organization Name . Ankyrbio . Announced Date Nov 22, 2019; Funding Type Grant; Money Raised . $225K. Lead Investors. Edit Lead Investors Section. National Science …See details»
AnkyrBio: Life-Changing Eye Therapeutics - Office of Innovation …
The AnkyrBio technology enables therapeutics to be administered in eye drops and remain active on the surface of the eye for up to 3-5 days. This unique technology localizes the therapeutics …See details»